An outstanding faculty of speakers from the United States and Europe has committed to participate in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumour types.

The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies, and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is the primary opportunity for practicing oncologists, haematologists, urologists, basic clinical and translational investigators, scientists and cancer related health care workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care.

The meeting does not charge a registration fee and the presentations are translated into Spanish in real time for the attendees.

We are looking forward to welcoming you to the exciting city of Buenos Aires and joining us for the conference!